Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |